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Abstract
Objective—A growing number of patients survive sepsis hospitalizations each year and are at 
high risk for readmission. However, little is known about temporal trends in hospital-based acute 
care (ED treat-and-release visits and hospital readmission) after sepsis. Our primary objective was 
to measure temporal trends in sepsis survivorship and hospital-based acute care use in sepsis 
survivors. In addition, because readmissions after pneumonia are subject to penalty under the 
national readmission reduction program, we examined whether readmission rates declined after 
sepsis hospitalizations related to pneumonia.
Design and Setting—Retrospective, observational cohort study conducted within an academic 
healthcare system from 2010 to 2015.
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Patients—We used three validated, claims-based approaches to identify 17,256 sepsis or severe 
sepsis hospitalizations to examine trends in hospital-based acute care after sepsis.
Interventions—None
Measurements and Main Results—From 2010–2015, sepsis as a proportion of medical and 
surgical admissions increased from 3.9% to 9.4%, while in-hospital mortality rate for sepsis 
hospitalizations declined from 24.1% to 14.8%. As a result, the proportion of medical and surgical 
discharges at-risk for hospital readmission after sepsis increased from 2.7% to 7.8%. Over 6 years, 
30-day hospital readmission rates declined modestly, from 26.4% in 2010 to 23.1% in 2015, 
driven largely by a decline in readmission rates amongst survivors of non-severe sepsis, and non-
pneumonia sepsis specifically, as the readmission rate of severe sepsis survivors was stable. The 
modest decline in 30-day readmission rates was offset by an increase in ED treat-and-release 
visits, from 2.8% in 2010 to a peak of 5.4% in 2014.
Conclusions—Owing to increasing incidence and declining mortality, the number of sepsis 
survivors at risk for hospital readmission rose significantly between 2010 and 2015. The 30-day 
hospital readmission rates for sepsis declined modestly but were offset by a rise in ED treat-and-
release visits.
Sepsis, an acute, life-threatening dysregulated response to infection, affects millions of 
patients within the United States annually and 30 million worldwide1,2. Studies indicate that 
the incidence of sepsis, known prior to 2016 as severe sepsis, is increasing at the national 
level3–5. At the same time, sepsis-related in-hospital mortality appears to be decreasing5–8.
Sepsis survivors frequently experience 30-day hospital readmissions9–19. The costs of 
hospital readmissions after sepsis have been estimated at 3 billion dollars19, reinforcing 
sepsis as the most expensive inpatient medical condition20. As part of the Affordable Care 
Act (ACA), passed in March of 2010, a Hospital Readmissions Reduction Program (HRRP) 
was developed. Starting in October 2012, financial penalties for hospitals with higher than 
expected 30-day readmission rates were implemented for targeted conditions (e.g., 
pneumonia). Despite being the most costly cause of readmission, sepsis is not a targeted 
condition of the HRRP.
Little is known about the relationship between sepsis incidence, in-hospital mortality, and 
post-discharge outcomes among sepsis survivors over time. Specific to sepsis survivorship, it 
is unclear whether the rate of hospital-based acute care use after sepsis, including 30-day 
hospital readmissions and Emergency Department (ED) treat-and-release visits, has changed 
over time. To examine these aspects of sepsis, which matter to patients and families21, we 
conducted a retrospective cohort study within an integrated academic medical center 
between 2010 and 2015. As a non-targeted condition of the HRRP, we hypothesized that the 
rate of hospital-based acute care use after sepsis, and 30-day readmission rate and ED treat-
and-release visits specifically, would remain stable (i.e., readmission rates would not 
decrease over time), leading to a rising number of readmissions that follow a recent sepsis 
hospitalization. Further, we hypothesized that readmission rates after pneumonia – a 
diagnosis targeted by the HRPP – would decrease over time.
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Methods
The University of Pennsylvania Institutional Review Board approved the study (Protocol # 
818852) with an informed consent exemption.
Study Design
We conducted a multicenter retrospective cohort study within the University of Pennsylvania 
Health System (UPHS), an integrated academic health care system consisting of 3 acute care 
hospitals in Philadelphia, PA: The Hospital of the University of Pennsylvania, Penn 
Presbyterian and Pennsylvania Hospital.
We evaluated adult medical and surgical admissions to UPHS hospitals between July 1 2010 
and June 30 2015. Given the outcomes of interest, and based on prior work9–10, 22, we 
excluded observation stays, admissions with a disposition of left against medical advice 
(AMA), transfer to another hospital, or when disposition was missing. In accord with the 
Agency for Healthcare Research and Quality approach to readmissions23, and prior 
work9–10, an admission could serve as an index admission and a hospital readmission. For 
analyses pertaining to re-hospitalization, we limited our analyses to patients discharged alive 
and not transitioned to hospice, hereafter known as discharges at-risk for hospital 
readmission. In accordance with our Institutional Review Board, admissions discharged to a 
correctional facility were excluded from our readmissions analyses.
Data Collection
To examine the incidence, mortality and readmission rates associated with sepsis 
hospitalizations, we merged administrative and electronic health record datasets. The quality 
of the administrative dataset using this approach had been previously validated24 and 
subsequent quality assurance performed9–10. As in prior studies9–10, we collected 
information on socio-demographics, comorbid conditions, and hospitalizations in the prior 
year, in addition to hospitalization details.
We identified sepsis using International Classification of Diseases, Ninth Revision, Clinical 
Modification (ICD-9-CM) codes, using previously validated approaches1,9–10, 24–25. As the 
study period pre-dated the 2016 definitions26, we used administrative codes that align with 
the categories of sepsis, severe sepsis, and septic shock in accord with the 2001 
definitions27. We identified sepsis hospitalizations using three approaches: (a) explicit 
diagnosis codes for sepsis (ICD-9-CM code 995.91), referred to hereafter as explicit sepsis, 
(b) explicit diagnoses codes for severe sepsis and septic shock (995.92, 785.52), referred to 
hereafter as explicit severe sepsis, and (c) modified Angus approach of concurrent ICD-9-
CM codes for infection (including codes for septicemia) and organ dysfunction1,24–25, 
referred to hereafter as implicit severe sepsis.
For comparison, we examined 30-day readmission rates after hospitalizations for acute 
myocardial infarction, congestive heart failure, and pneumonia (independent of sepsis status) 
over the study period using established ICD-9-CM codes.22 These conditions were selected 
as they are the high-risk conditions targeted by the HRRP at is inception. Because coding for 
pneumonia has varied over time28, and given our hypotheses, we also used the pneumonia 
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and sepsis codes to identify three discrete admission categories: (a) pneumonia, non-sepsis 
admissions, (b) sepsis related to pneumonia admissions, and (c) non-pneumonia sepsis 
admissions.
Statistical Analyses
To understand temporal changes in sepsis survivorship, we focused on trends in sepsis 
hospitalizations, sepsis survivors at-risk for hospital readmission, and post-acute care use 
after sepsis. For post-acute care use, we examined 7- and 30-day all-cause hospital 
readmission and ED treat-and-release visits within 30 days9,29. We used a nonparametric test 
for trend across ordered groups (i.e., year) using the nptrend package in the Stata statistical 
software for the primary analysis.30 This method is an extension of the Wilcoxon rank-sum 
test but differs in that it examines the ranks for the variable of interest across ordered 
groups30.
First, we measured the incidence of sepsis hospitalizations and tested for changes over time. 
We completed this analysis separately for each sepsis coding strategy (explicit sepsis, 
explicit severe sepsis, and implicit severe sepsis). Next, we measured in-hospital sepsis-
related mortality, and again tested for changes over time. Additionally, we evaluated the 
trends in a composite of in-hospital mortality and discharge to hospice to account for 
potential hospice discharge practice changes. We also measured whether the proportion of 
deaths related to sepsis changed over time. We then examined the characteristics of sepsis 
survivors at-risk for hospital readmission over time.
Next, we evaluated 7- and 30-day all-cause hospital readmissions among sepsis survivors 
over time. We examined 30-day hospital readmissions after sepsis, and by discrete sepsis 
coding strategy, by year, to determine whether changes in readmission rates were driven by 
explicit cases and/or illness severity.
To examine whether readmission rates differed over time according to pneumonia status, we 
examined readmission rates among the three, aforementioned subgroups: pneumonia, non-
sepsis admissions, sepsis related to pneumonia admissions, and non-pneumonia sepsis 
admissions. As 2010 data began July 1, and 2015 data ended June 30th, annualized volume is 
presented for these years.
We present the temporal trends in incidence, in-hospital mortality, in-hospital mortality and 
discharge to hospice, and 30-day readmission, at the monthly level, using 95% confidence 
intervals in graphical format using a local polynomial smoothing function. For statistical 
analyses, we used Stata 13 (StataCorp, College Station, Texas). We defined significance as 
an alpha less than 0.05.
Results
After excluding 80,423 non-medical, non-surgical health system admissions (e.g., 
obstetrics), 2286 admissions where the patient left AMA, 1777 admissions transferred to an 
outside hospital, and 333 admissions missing a disposition status, there were 275,600 
medical and surgical admissions over 5 years. Of these 275,600 hospitalizations, 17,256 
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were sepsis hospitalizations (6.3%, 95% confidence interval: 6.2, 6.4), including 7,603 
explicit sepsis, 9,709 explicit severe sepsis, and 11,618 implicit severe sepsis.
As shown in Table 1 and Figure 1, Panel A, from 2010 to 2015, the proportion of sepsis 
hospitalizations increased more than two-fold, from 3.9% to 9.4% (p<0.001); the absolute 
number increased from 2224 in 2010 to 4928 in 2015. Sepsis hospitalizations increased 
more than two-fold over time and independent of sepsis coding strategy (p<0.001 for 
explicit sepsis, explicit severe sepsis, and implicit severe sepsis).
The in-hospital mortality rate for sepsis hospitalizations declined from 24.1% to 14.8% 
(p<0.001) (Figure 1, Panel B). Mortality declined over time for all sepsis definitions, 
p<0.001 (Supplemental Table 1). Despite the decline in sepsis case-fatality rate, given the 
increase in sepsis incidence, the total number of sepsis-related deaths increased from 536 to 
728 from 2010 to 2015, and sepsis contributed to a higher percentage of in-hospital deaths 
over time (43.4% in 2010 to 55.4% in 2015, Figure 1, Panel C).
As a result of rising sepsis hospitalizations and declining in-hospital mortality, the 
proportion of medical and surgical discharges at-risk for hospital readmission after a sepsis 
hospitalization (i.e., sepsis survivors) increased 2.9-fold, from 2.7% in 2010 to 7.8% in 2015 
(Figure 1, Panel D). The overall number of sepsis survivors at-risk for readmission increased 
from 1,502 in 2010 to 3,900 in 2015. The proportion of discharges at-risk for hospital 
readmission after a pneumonia hospitalization, regardless of sepsis status, began at a higher 
volume of cases, yet increased just 1.2-fold (2186 hospitalizations in 2010 to 2684 in 2015).
As shown in Supplemental Table 2, the age of sepsis survivors did not differ significantly 
over time. Clinically important differences, over time, include: a shift in demographics (e.g., 
more female survivors), a shift in comorbid conditions (e.g., less malignancy amongst 
survivors), lower illness severity during the hospitalization (e.g., less ICU admission, shock, 
use of mechanical ventilation, procedures, and shorter hospital length of stay), and survivors 
were more likely to be discharged to home health services (26.9% to 33.5% over 6 years) 
and less likely to be discharged to skilled care or long-term acute care facilities.
Over 6 years, the 7- and 30-day hospital readmission rate of sepsis survivors declined 
modestly, from 8.9% to 8.3% and 26.4% to 23.1%, respectively (Table 2). As a contrast, the 
30-day hospital readmission rates were 10.8%, 18.2%, and 21.1% after acute myocardial 
infarction, heart failure, and pneumonia hospitalizations, respectively, and rates did not 
decline for any of these conditions between 2010 and 2015 (p=0.67, p=0.14, and p=0.84 for 
trend).
The decline in 30-day all-cause hospital readmission after sepsis was offset by an increase in 
the rate of ED treat-and-release visits (from 2.8% in 2010 to a peak of 5.4% in 2014, 
p=0.001). Additionally, despite the modest decline in readmission rates after sepsis, the total 
number of 7- and 30-day hospital readmissions of sepsis survivors increased nearly three-
fold, from 134 to 324, and 396 to 900, respectively.
The modest decline in 30-day all-cause hospital readmission after sepsis was present 
amongst explicit sepsis cases (p=0.005), but not among explicit or implicit severe sepsis 
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cases (p=0.49 and p=0.77, respectively) (Table 3). After combining explicit and implicit 
severe sepsis coding strategies, 30-day hospital readmission rates declined from 27.6% in 
2010 to 22.9% in 2015 after sepsis (p=0.005), but not after severe sepsis (26.4% in 2010 to 
24.4% in 2015, p=0.58) (Supplemental Table 3). Contrary to our hypothesis, the declining 
readmission rate after sepsis was not explained by pneumonia admissions. Rather, there was 
a modest reduction in readmission rates after non-pneumonia sepsis admissions (p=0.01).
Discussion
In this multicenter observational study within an academic health system, we examined 
trends in hospital-based acute care use after sepsis, including 30-day hospital readmissions 
and Emergency Department treat-and-release visits, over a six-year period. Consistent with 
previous reports using national data1,3–5,31–34, we found a rising volume of sepsis 
hospitalizations and declining in-hospital mortality rate. As a result, sepsis survivors at-risk 
for hospital readmission increased nearly three-fold over time, suggesting that the growing 
number of sepsis survivors is not limited to Medicare beneficiaries35. Given the long-term 
consequences of sepsis, which include recurrent infections and cognitive and physical 
impairment10–11,36–37, this is a significant public health threat.
We found that the characteristics of sepsis survivors changed over time (e.g., more female 
survivors, lesser illness severity). For example, in 2010, 57% of sepsis survivors required 
ICU admission, compared to 35% in 2015. These observations reinforce the Stage Migration 
Effect (i.e., with increased awareness comes increased identification, often of cases with 
milder stages of disease).38 These temporal shifts also highlight the importance of raising 
awareness of sepsis survivorship across ICUs and wards, both for evaluating the past 
medical history of newly admitted patients (i.e., is this patient a sepsis survivor?) and for 
discharge planning and anticipatory guidance, as 42% of hospital-based care encounters 
after sepsis may be preventable with effective out-patient management.15
Between 2010 and 2015, the rate of 7- and 30-day hospital readmission after sepsis 
remained high, with rates higher than the HRRP targeted conditions. While 30-day 
readmission rates declined, the improvements were modest, decreasing from 28% in 2010 to 
23% in 2015 after explicit sepsis and from 26% in 2010 to 24% in 2015 after severe sepsis. 
We found that readmission rates were largely similar after sepsis and severe sepsis, and both 
exceeded nationally targeted conditions. These findings, which suggest that patients 
hospitalized with infection who exhibit a systemic inflammatory response without overt 
organ dysfunction (i.e., sepsis in Sepsis-2) incur a readmission risk similar to those with 
organ dysfunction, require confirmation.
Further, the modest reduction in the 30-day hospital readmission rate was offset by an 
increase in the rate of ED treat-and-release visits. As a result, the rate of hospital-based acute 
care use after sepsis remained largely unchanged. Coupled with an expanding population of 
sepsis survivors, the total number of 30-day hospital readmissions after sepsis increased 
three-fold over 6 years.
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Recent evaluations of the national impact of the HRRP demonstrated declines in hospital 
readmissions among targeted conditions and non-targeted conditions, with greater declines 
in the targeted conditions39. Contrary to our hypothesis, we did not observe a decline in 
readmission rates after pneumonia. Rather, we found that readmission rates declined 
modestly among non-pulmonary sources of sepsis (e.g., urinary tract infection) and, 
potentially related, among those with less severe cases (e.g., explicit sepsis). While there is 
no clear signal that readmission rates differ by source of infection at the time of the index 
admission10, additional studies examining the relationship between the index sepsis 
admission and infection-related readmission are needed.
Our findings support the growing recommendations that sepsis warrants national attention as 
a targeted condition for acute care and post-acute care performance metrics18,40–41. To date, 
there has been little evaluation of hospital discharge practices after sepsis. We previously 
reported a notable lack of timely post-discharge follow-up for septic shock survivors, as 
most survivors are readmitted within 14 days11, leaving many readmitted prior to their 
scheduled appointments. Even less attention is placed on what should happen during 
primary care follow-up visits after sepsis. Notably, nearly 70% of unplanned hospital 
readmissions after sepsis are due to infections--about half of which are relapse or recrudesce 
of the initial infection and half are new11,42. Such results suggest that sepsis survivors are 
particularly susceptible to reinfection and may benefit from careful monitoring for 
recrudescence of infections.
The required care coordination is specifically challenging among this patient population, as 
sepsis survivors are two times more likely to be discharged to skilled nursing facilities and 
ten times more likely to require long term acute care hospital placement compared to non-
sepsis patients9. To improve post-discharge outcomes after sepsis, comprehensive, 
coordinated multidisciplinary approaches to caring for sepsis survivors are needed. Given 
the growth in home health services that we observed after sepsis, and evidence that early and 
intense home health visits can reduce hospital readmission43, novel interventions applied to 
home health services and focused on ambulatory care sensitive conditions15 for sepsis 
survivors are warranted. A successful program will likely include a number of facets, 
including continuity between inpatient, post-acute care services, and outpatient providers, 
antibiotic stewardship, management of sepsis specific impairments, and surveillance for new 
or recurrent infection. Provider education will be an essential component, but likely 
incomplete without engaging survivors and caregivers to facilitate self-care. Empowerment, 
potentially augmented by survivors supporting one another44, could expedite realization of 
readmission reductions45.
Our findings suggest a number of future directions. First, investigation is warranted to 
determine the role that readmissions, and infection-related readmissions in particular, play in 
the long-term mortality risk of sepsis survivors. Future studies should examine the timing 
and location of death and hospice use in the year after sepsis. Second, given the growth in 
ED treat-and-release visits, a greater understanding of the nature of treatment delivered 
during these encounters, and subsequent outcomes, are warranted. Third, post-discharge, 
novel surveillance strategies, leveraging mobile health technology, may prove useful to 
identify a new or recurrent infection. Last, while studies have examined risk factors 
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associated with hospital readmission after sepsis, important questions (e.g., do outcomes 
differ between culture-positive and culture-negative sepsis cases) remain unanswered.
Limitations
There are important limitations to this study. This study is limited to three hospitals within a 
single academic center; confirmatory studies are justified. Although we included hospital 
transfers to increase our readmission captures, we acknowledge that the rate is likely an 
underestimate as we were unable to identify readmissions outside of UPHS. However, we 
are not aware of any systematic changes over the study period that would bias the 
measurements of trend. There is no perfect method for identifying sepsis hospitalizations in 
claims data and we acknowledge temporal trends in clinical documentation and coding 
practice. For this reason, we used multiple, validated methods to identify sepsis 
hospitalizations. As sepsis cohorts derived from administrative datasets tend to be more 
severely ill24, changes in documentation likely reflect a more accurate picture of the overall 
disease burden of sepsis and its outcomes, while admittedly overestimating the increase in 
sepsis incidence and the decline in sepsis-related mortality. Future studies should utilize 
objective clinical data based abstraction methods to confirm our findings related to hospital 
readmissions.
Conclusion
In a retrospective cohort study conducted within an academic center over 6 years, we 
observed a growing population of sepsis survivors who experienced a high rate of 7- and 30-
day hospital readmissions. The modest decline in 30-day hospital readmission rates after 
sepsis was countered by a rise in ED treat-and-release visits, revealing a potential shift in 
hospital-based acute care after sepsis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Temporal trends in sepsis from 2010 to 2015. Panel A depicts the proportion of sepsis 
hospitalizations among medical and surgical admissions. Panel B depicts in-hospital 
mortality and in-hospital mortality or transition to hospice at discharge amongst sepsis 
hospitalizations, respectively. Panel C depicts the proportion of deaths where sepsis 
contributed. Panel D depicts the proportion of medical and surgical admissions discharged 
alive and at-risk for hospital readmission over the same time interval. The temporal trends 
and the 95% confidence intervals were estimated using a local polynomial smoothing 
function with a bandwidth chosen as the plugin estimator of the asymptotically optimal 
constant bandwidth.
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Table 1
Test for trends in sepsis as a proportion of hospital admissions, in-hospital mortality among sepsis admissions, 
and sepsis survivors as a proportion of discharges at-risk for hospital readmission.
Year Sepsis,
% of Hospital
Admissions *
In-Hospital Mortality,
% for Sepsis
Hospitalizations *
Sepsis Survivors, %
of Discharges At-
Risk for Hospital
Readmission *
2010 3.87 (1112/28740) 24.10 (268/1112) 2.72 (751/27608)
2011 4.15 (2420/58310) 23.10 (559/2420) 2.99 (1669/55902)
2012 5.63 (3152/55962) 18.56 (585/3152) 4.35 (2327/53498)
2013 6.88 (3686/53541) 17.55 (647/3686) 5.38 (2743/51004)
2014 8.37 (4422/52841) 15.54 (687/4422) 6.71 (3367/50216)
2015 9.40 (2464/26206) 14.77 (364/2464) 7.80 (1950/24997)
*Significant test for trend, p<0.05.
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Table 2
Trends in 7- and 30-day hospital readmissions and 30-day emergency department (ED) treat-and-release visits 
after sepsis.
Year 7-Day Hospital
Readmission, % *
30-Day ED Treat-and-
Release Visit, % *
30-Day Hospital
Readmission, % *
2010 8.92 (67/751) 2.80 (21/751) 26.36 (198/751)
2011 9.89 (165/1669) 3.36 (56/1669) 26.30 (439/1669)
2012 8.59 (200/2327) 4.51 (105/2327) 26.56 (618/2327)
2013 9.15 (251/2743) 5.21 (143/2743) 25.96 (712/2743)
2014 7.45 (251/3367) 5.41 (182/3367) 24.98 (841/3367)
2015 8.31 (162/1950) 4.67 (91/1950) 23.08 (450/1950)
*Significant test for trend, p<0.05.
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Table 3
Trends in 30-day hospital readmission rates after sepsis admissions identified using explicit codes and severe 
sepsis identified using explicit and implicit codes and by pneumonia status.
Readmission Rates by Explicit and Implicit Codes
Year 30-Day Hospital Readmission Rates After 
Explicit Sepsis, % *
30-Day Hospital Readmission Rates After 
Explicit Severe Sepsis, %
30-Day Hospital Readmission Rates After 
Implicit Severe Sepsis, %
2010 27.61 (103/373) 25.41 (94/370) 26.69 (126/472)
2011 27.15 (227/836) 25.58 (210/821) 25.64 (270/1053)
2012 25.95 (288/1110) 27.19 (332/1221) 27.06 (390/1441)
2013 23.63 (337/1426) 28.50 (375/1316) 28.05 (451/1608)
2014 23.93 (457/1910) 26.36 (387/1468) 26.85 (504/1877)
2015 22.89 (263/1149) 23.40 (190/812) 24.95 (261/1046)
Readmission Rates by Pneumonia and Sepsis Status
Year 30-Day Hospital Readmission After 
Pneumonia, Non-Sepsis Admissions, %
30-Day Hospital Readmission After 
Sepsis Related to Pneumonia Admissions, 
%
30-Day Hospital Readmission After Non-
Pneumonia Sepsis Admissions, % *
2010 18.32 (174/950) 23.78 (34/143) 26.97 (164/608)
2011 20.11 (418/2079) 23.23 (95/409) 27.30 (344/1260)
2012 21.82 (384/1760) 25.42 (135/531) 26.89 (483/1796)
2013 20.75 (344/1658) 26.27 (166/632) 25.86 (546/2111)
2014 18.48 (287/1553) 25.09 (199/793) 24.94 (642/2574)
2015 19.51 (168/861) 20.37 (98/481) 23.96 (352/1469)
*Significant test for trend, p<0.05.
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